Literature DB >> 24324267

Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-β signaling.

Yili Feng1, Hongxing Wu, Yongxian Xu, Zhengmao Zhang, Ting Liu, Xia Lin, Xin-Hua Feng.   

Abstract

ZNF451 is a transcriptional cofactor localized to promyelocytic leukemia bodies. Here, we present evidence demonstrating that ZNF451 physically interacts with Smad3/4 and functionally inhibits TGF-β signaling. Increased expression of ZNF451 attenuates TGF-β-induced growth inhibitory and gene transcriptional responses, whereas depletion of ZNF451 enhances TGF-β responses. Mechanistically, ZNF451 blocks the ability of Smad3/4 to recruit p300 in response to TGF-β, which causes reduction of histone H3K9 acetylation on the promoters of TGF-β target genes. Taken together, ZNF451 acts as a transcriptional corepressor for Smad3/4 and negatively regulates TGF-β signaling.

Entities:  

Keywords:  SMAD Transcription Factor; Signal Transduction; Transcription Repressor; Transforming Growth Factor β (TGFβ); Zinc Finger

Mesh:

Substances:

Year:  2013        PMID: 24324267      PMCID: PMC3900955          DOI: 10.1074/jbc.M113.526905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Zinc finger proteins: new insights into structural and functional diversity.

Authors:  J H Laity; B M Lee; P E Wright
Journal:  Curr Opin Struct Biol       Date:  2001-02       Impact factor: 6.809

Review 2.  Engineering polydactyl zinc-finger transcription factors.

Authors:  Roger R Beerli; Carlos F Barbas
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

3.  Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.

Authors:  Tamara Alliston; Tien C Ko; Yanna Cao; Yao-Yun Liang; Xin-Hua Feng; Chenbei Chang; Rik Derynck
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

4.  Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B).

Authors:  Xin-Hua Feng; Yao-Yun Liang; Min Liang; Weiguo Zhai; Xia Lin
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

5.  The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.

Authors:  M Tascilar; H G Skinner; C Rosty; T Sohn; R E Wilentz; G J Offerhaus; V Adsay; R A Abrams; J L Cameron; S E Kern; C J Yeo; R H Hruban; M Goggins
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

6.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

7.  c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.

Authors:  S Akiyoshi; H Inoue; J Hanai; K Kusanagi; N Nemoto; K Miyazono; M Kawabata
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

8.  Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta -induced physical and functional interactions between smads and Sp1.

Authors:  P K Datta; M C Blake; H L Moses
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 9.  TGF-beta signaling in tumor suppression and cancer progression.

Authors:  R Derynck; R J Akhurst; A Balmain
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

Review 10.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

Authors:  H M Chan; N B La Thangue
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  19 in total

1.  Copy-number variant analysis of classic heterotaxy highlights the importance of body patterning pathways.

Authors:  Erin M Hagen; Robert J Sicko; Denise M Kay; Shannon L Rigler; Aggeliki Dimopoulos; Shabbir Ahmad; Margaret H Doleman; Ruzong Fan; Paul A Romitti; Marilyn L Browne; Michele Caggana; Lawrence C Brody; Gary M Shaw; Laura L Jelliffe-Pawlowski; James L Mills
Journal:  Hum Genet       Date:  2016-09-15       Impact factor: 4.132

Review 2.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

3.  ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.

Authors:  Wang Zeng; Shuchen Gu; Yi Yu; Yili Feng; Mu Xiao; Xin-Hua Feng
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

Review 4.  Transcriptional Control by the SMADs.

Authors:  Caroline S Hill
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

5.  SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.

Authors:  Sisi Liu; Jianyin Long; Bo Yuan; Mingjie Zheng; Mu Xiao; Jianming Xu; Xia Lin; Xin-Hua Feng
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

6.  Cell proliferation downregulated by TGF-β2-triggered G1/S checkpoint in clinical CAFs.

Authors:  Jinliang Wu; Rong Fu; Zongzhi Liu; Guochao Li; Xiaolei Huang; Yang Xue; Yan Xu; Yingli Sun; Jiangmin Zhao; Jun Mi
Journal:  Cell Cycle       Date:  2016-11-23       Impact factor: 4.534

7.  Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.

Authors:  Jia-Cheng Tang; Jing-Hua Liu; Xiao-Long Liu; Xiao Liang; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

8.  ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.

Authors:  Mu Xiao; Shuchen Gu; Yongxian Xu; Qianting Zhang; Ting Liu; Hao Li; Yi Yu; Lan Qin; Yezhang Zhu; Fenfang Chen; Yulong Wang; Chen Ding; Hongxing Wu; Hongbin Ji; Zhe Chen; Youli Zu; Stephen Malkoski; Yi Li; Tingbo Liang; Junfang Ji; Jun Qin; Pinglong Xu; Bin Zhao; Li Shen; Xia Lin; Xin-Hua Feng
Journal:  Nat Cell Biol       Date:  2019-01-21       Impact factor: 28.824

9.  Alternative splicing and co-option of transposable elements: the case of TMPO/LAP2α and ZNF451 in mammals.

Authors:  Federico Abascal; Michael L Tress; Alfonso Valencia
Journal:  Bioinformatics       Date:  2015-03-02       Impact factor: 6.937

10.  Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.

Authors:  Roseanne Raphael; Diana Purushotham; Courtney Gastonguay; Marla A Chesnik; Wai-Meng Kwok; Hsiang-En Wu; Sanjiv J Shah; Shama P Mirza; Jennifer L Strande
Journal:  J Transl Med       Date:  2016-01-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.